期刊文献+

度洛西汀与帕罗西汀治疗抑郁症对照观察 被引量:8

A clinical control study of Duloxetine and paroxetine in the treatment of depression
下载PDF
导出
摘要 目的比较度洛西汀和帕罗西汀治疗门诊抑郁症的疗效和副反应。方法 将符合CCMD-3抑郁症诊断标准的患者随机分为两组,分别给予度洛西汀及帕罗西汀治疗,治疗时间为6周,使用汉密尔顿抑郁量表(HAMD)、临床总体印象量表(CGI)、不良反应症状量表(TESS)进行评分。结果 两组有效率分别为80%和87%,在疗效和副反应方面两组差异无显著性。结论 度洛西汀是一种疗效好而安全的抗抑郁药,适用于门诊抑郁症患者。 Objective To compare clinical efficacy and side effects between Duloxetine and paroxetine in the treatment of depression in outpatients. Methods 62 patients who met CCMD - 2 - R for de - pression were randomly assigned to 2 groups. One group was treated with Duloxetine and the otherwith paroxetine for six weeks. Hamilton rating scale (HAMD), clinical global impression scale (CGI), and treatment emergent symptom scale (TESS) were used to assess. Results Total clinical effectiverate was 80% for Duloxetine group and 87% for paroxetine group. There were no differences in clinicaleffects and adverse reactions between the two groups. Conclusion The results indicate that Duloxetine is a safe and effective drug for the treatment of depression in outpatients.
出处 《中外医学研究》 2011年第1期16-17,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 抑郁症 度洛西汀 帕罗西汀 Depression Duloxetine Paroxetine
  • 相关文献

参考文献5

  • 1张明圆.精神科评定量表手册[M].长沙:湖南科技出版社,1998..
  • 2Costa E,Silvs J.Randomized,double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.JClin Psychiatry,1998,59:352.
  • 3李冰,王祖新.万拉法新治疗抑郁症的临床验证[J].上海精神医学,1997,9(4):269-272. 被引量:67
  • 4Ferrier IN.Treatment of major depression:is improvement enough J Clin Psychiatry,1999,(Suppl 60):10.
  • 5Rudolph RL.Arandomized,placebo-controlled,dose-responsetrial of venlafaxine hydrochloride in the treatment of major depression.J Clin Psychiatry,1998,59:116.

共引文献267

同被引文献76

  • 1陈泽奇,胡随瑜,张海男,张宏耕,郑林,李晓照.抑郁症常见中医证候标准的研究[J].中医杂志,2005,46(1):47-49. 被引量:71
  • 2马欢.抑郁症病因病机研究探析[J].辽宁中医杂志,2005,32(6):537-538. 被引量:53
  • 3黄诚,邵胜利,柳振清.血液流变学在精神疾病治疗上的应用动态[J].四川精神卫生,1996,9(2):139-140. 被引量:17
  • 4王琪,赵建军.疏肝解郁法为主治疗脑卒中后抑郁90例临床观察[J].长春中医药大学学报,2007,23(2):50-51. 被引量:24
  • 5Greden JF.e burden of disease for treatment-resistant depression.J Clin Psychiatry,2001,62 Suppl 16:26-31.
  • 6Perahia DG,Quail D,Desaiah D,et al.Switching to duloxetine inselective serotonin reuptake inhibitor non-and partial-responders:e ects on painful physical symptoms of depression.J Psychiatr Res,2009,43(5):512-518.
  • 7Knadler MP,Lobo E,Chappell J,et al.Duloxetine:clinical pharma-cokinetics and drug interactions.Clin Pharmacokinet,2011,50(5):281-294.
  • 8Cipriani A,Furukawa TA,Salanti G,et al.Comparative efficacyand acceptability of 12 new-generation antidepressants:a multiple-treatments meta-analysis.Lancet,2009,373(9665):746-758.
  • 9Cremers TI,Rea K,Bosker FJ,et al.Augmentation of SSRI e ects onserotonin by 5-HT2C antagonists:mechanistic studies.Neuropsy-chopharmacology,2007,32(7):1550-1557.
  • 10Gueorguieva R,Mallinckrodt C,Krystal JH.Trajectories of depres-sion severity in clinical trials of duloxetine:insights into antidepres-sant and placebo responses.Arch Gen Psychiatry,2011,68(12):1227-1237.

引证文献8

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部